Orthocell Ltd
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally. It offers Ortho Autologous Chondrocyte Implantation, a cartilage cell therapy for treatment of articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membr… Read more
Orthocell Ltd (OCC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.211x
Based on the latest financial reports, Orthocell Ltd (OCC) has a cash flow conversion efficiency ratio of -0.211x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.07 Million) by net assets (AU$14.57 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Orthocell Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Orthocell Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Orthocell Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Orthocell Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhuhai Sailong Pharmaceutical Co Ltd
SHE:002898
|
-0.062x |
|
Shandong Molong Petroleum Machinery Company Limited
PINK:SHANY
|
N/A |
|
K.P. Energy Limited
NSE:KPEL
|
N/A |
|
PROQR THERAPEUTICS EO-04
F:0PQ
|
N/A |
|
Syscom Computer Engineering Co
TW:2453
|
-0.212x |
|
MicroPort CardioFlow Medtech Corporation
PINK:MROPF
|
N/A |
|
X-Legend Entertainment Co Ltd
TW:4994
|
0.030x |
|
icad inc
NASDAQ:ICAD
|
0.002x |
Annual Cash Flow Conversion Efficiency for Orthocell Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of Orthocell Ltd from 2013 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$14.57 Million | AU$-8.68 Million | -0.596x | +58.47% |
| 2024-06-30 | AU$4.53 Million | AU$-6.51 Million | -1.435x | -160.48% |
| 2023-06-30 | AU$6.15 Million | AU$14.59 Million | 2.373x | +475.40% |
| 2022-06-30 | AU$9.90 Million | AU$-6.26 Million | -0.632x | -130.23% |
| 2021-06-30 | AU$16.87 Million | AU$-4.63 Million | -0.275x | -9.18% |
| 2020-06-30 | AU$20.90 Million | AU$-5.26 Million | -0.251x | +35.49% |
| 2019-06-30 | AU$10.72 Million | AU$-4.18 Million | -0.390x | +80.09% |
| 2018-06-30 | AU$2.37 Million | AU$-4.64 Million | -1.958x | -159.49% |
| 2017-06-30 | AU$4.71 Million | AU$-3.56 Million | -0.754x | -10.96% |
| 2016-06-30 | AU$4.88 Million | AU$-3.32 Million | -0.680x | -7.70% |
| 2015-06-30 | AU$4.38 Million | AU$-2.77 Million | -0.631x | +97.26% |
| 2014-06-30 | AU$76.19K | AU$-1.75 Million | -23.009x | -8434.14% |
| 2013-06-30 | AU$1.08 Million | AU$-290.57K | -0.270x | -- |